Canada’s Growing Hotbed For Biotechnology Investing
“There is a reason Sanderling has a dominant portion of its portfolio companies located in Canada; all based on good technology, knowledgeable drug development and sound economics.” When Robert McNeil founded Sanderling Ventures in 1979 he didn’t immediately have his sights set on Canada. After all, biotech investing in the country lagged that of our